57 related articles for article (PubMed ID: 28954785)
1. The Driver Mutational Landscape of Ovarian Squamous Cell Carcinomas Arising in Mature Cystic Teratoma.
Cooke SL; Ennis D; Evers L; Dowson S; Chan MY; Paul J; Hirschowitz L; Glasspool RM; Singh N; Bell S; Day E; Kochman A; Wilkinson N; Beer P; Martin S; Millan D; Biankin AV; McNeish IA;
Clin Cancer Res; 2017 Dec; 23(24):7633-7640. PubMed ID: 28954785
[No Abstract] [Full Text] [Related]
2. Squamous cell carcinoma initially occurring on the tongue dorsum: a case series report with molecular analysis.
Ono S; Hirose K; Sukegawa S; Obata K; Masui M; Hasegawa K; Fujimura A; Shimada K; Nakamura S; Teramoto A; Hori Y; Morii E; Motooka D; Igawa T; Tanaka T; Nagatsuka H; Toyosawa S; Yamamoto H
Diagn Pathol; 2024 Apr; 19(1):63. PubMed ID: 38650013
[TBL] [Abstract][Full Text] [Related]
3. MR diagnosis of SCC arising within ovarian cystic teratomas: analysis of mural nodule characteristics.
Fukuzawa T; Ohya A; Tanaka M; Shimizu M; Kobayashi K; Matsushita T; Watanabe T; Kobara H; Fujinaga Y
Abdom Radiol (NY); 2024 Apr; 49(4):1264-1274. PubMed ID: 38393356
[TBL] [Abstract][Full Text] [Related]
4. MRI findings of malignant transformation arising from mature cystic teratoma of the ovary: comparison with benign mature cystic teratoma.
Kawaguchi M; Kato H; Furui T; Noda Y; Hyodo F; Miyazaki T; Matsuo M
Jpn J Radiol; 2024 May; 42(5):500-507. PubMed ID: 38146022
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience in ovarian squamous cell carcinoma arising from mature cystic teratoma: A rare entity.
Choi EJ; Koo YJ; Jeon JH; Kim TJ; Lee KH; Lim KT
Obstet Gynecol Sci; 2014 Jul; 57(4):274-80. PubMed ID: 25105100
[TBL] [Abstract][Full Text] [Related]
6. Temporal dissection of tumorigenesis in primary cancers.
Durinck S; Ho C; Wang NJ; Liao W; Jakkula LR; Collisson EA; Pons J; Chan SW; Lam ET; Chu C; Park K; Hong SW; Hur JS; Huh N; Neuhaus IM; Yu SS; Grekin RC; Mauro TM; Cleaver JE; Kwok PY; LeBoit PE; Getz G; Cibulskis K; Aster JC; Huang H; Purdom E; Li J; Bolund L; Arron ST; Gray JW; Spellman PT; Cho RJ
Cancer Discov; 2011 Jul; 1(2):137-43. PubMed ID: 21984974
[TBL] [Abstract][Full Text] [Related]
7. Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.
Megquier K; Turner-Maier J; Swofford R; Kim JH; Sarver AL; Wang C; Sakthikumar S; Johnson J; Koltookian M; Lewellen M; Scott MC; Schulte AJ; Borst L; Tonomura N; Alfoldi J; Painter C; Thomas R; Karlsson EK; Breen M; Modiano JF; Elvers I; Lindblad-Toh K
Mol Cancer Res; 2019 Dec; 17(12):2410-2421. PubMed ID: 31570656
[TBL] [Abstract][Full Text] [Related]
8. An integrated inspection of the somatic mutations in a lung squamous cell carcinoma using next-generation sequencing.
Stead LF; Egan P; Devery A; Conway C; Daly C; Berri S; Wood H; Belvedere O; Papagiannopoulos K; Ryan A; Rabbitts P
PLoS One; 2013; 8(11):e78823. PubMed ID: 24244370
[TBL] [Abstract][Full Text] [Related]
9. Genomic and transcriptomic plasticity in treatment-naive ovarian cancer.
Hoogstraat M; de Pagter MS; Cirkel GA; van Roosmalen MJ; Harkins TT; Duran K; Kreeftmeijer J; Renkens I; Witteveen PO; Lee CC; Nijman IJ; Guy T; van 't Slot R; Jonges TN; Lolkema MP; Koudijs MJ; Zweemer RP; Voest EE; Cuppen E; Kloosterman WP
Genome Res; 2014 Feb; 24(2):200-11. PubMed ID: 24221193
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma of intestinal type arising in mature cystic teratoma of ovary: A diagnostic dilemma.
Belaid I; Khechine W; Ben Abdelkader A; Bedioui A; Ezzairi F; Chabchoub I; Boujnah R; Tlili T; Hochlaf M; Ben Fatma L; Mokni M; Ben Ahmed S
Clin Case Rep; 2020 Apr; 8(4):644-647. PubMed ID: 32274027
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma transformation in mature cystic teratoma of the ovary: a systematic review.
Li C; Zhang Q; Zhang S; Dong R; Sun C; Qiu C; Zhang Z; Yang X; Kong B
BMC Cancer; 2019 Mar; 19(1):217. PubMed ID: 30866852
[TBL] [Abstract][Full Text] [Related]
12. XCL1 expression correlates with CD8-positive T cells infiltration and PD-L1 expression in squamous cell carcinoma arising from mature cystic teratoma of the ovary.
Tamura R; Yoshihara K; Nakaoka H; Yachida N; Yamaguchi M; Suda K; Ishiguro T; Nishino K; Ichikawa H; Homma K; Kikuchi A; Ueda Y; Takei Y; Fujiwara H; Motoyama T; Okuda S; Wakai T; Inoue I; Enomoto T
Oncogene; 2020 Apr; 39(17):3541-3554. PubMed ID: 32115573
[TBL] [Abstract][Full Text] [Related]
13. Metastatic squamous cell carcinoma arising from mature teratoma of the ovary: Description of multi-modality treatment including incorporation of adjuvant immunotherapy and maintenance PARP inhibitor therapy.
Peluso E; Fowler Edwards W; Marie Tran Janco J
Gynecol Oncol Rep; 2024 Apr; 52():101371. PubMed ID: 38558963
[TBL] [Abstract][Full Text] [Related]
14. Recurrent squamous cell carcinoma arising in ovary mature cystic teratoma: A case report.
Ji X; Zhai P; Yang H; Wang H; Wang X
Medicine (Baltimore); 2023 Aug; 102(32):e34734. PubMed ID: 37565860
[TBL] [Abstract][Full Text] [Related]
15. Genomic profiling of a metastatic anaplastic melanocytic neuroectodermal tumor arising from a mature thymic teratoma as part of a mediastinal germ cell tumor.
Mayeur S; Lhermitte B; Gantzer J; Molitor A; Stemmelen T; Meyer S; Kolmer A; Kurtz JE; Bahram S; Carapito R
Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 37160315
[TBL] [Abstract][Full Text] [Related]
16. Use of platinum-based chemotherapy and pembrolizumab to treat squamous cell carcinoma arising in a mature teratoma of the ovary in a pre-menopausal woman with negative response: A case report.
Martel RA; Marsh L; Lai T; Rodriguez-Triana VM; Moatamed NA; Cohen J
Gynecol Oncol Rep; 2023 Jun; 47():101192. PubMed ID: 37131341
[TBL] [Abstract][Full Text] [Related]
17. Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma.
Tamura R; Nakaoka H; Yachida N; Ueda H; Ishiguro T; Motoyama T; Inoue I; Enomoto T; Yoshihara K
Cancer Sci; 2023 May; 114(5):2145-2157. PubMed ID: 36762791
[TBL] [Abstract][Full Text] [Related]
18. Nivolumab for malignant transformation of ovarian mature cystic teratoma.
Yoshimura K; Yamanoi K; Kanai M; Okunomiya A; Sagae Y; Sunada M; Taki M; Ukita M; Chigusa Y; Horie A; Yamaguchi K; Hamanishi J; Minamiguchi S; Yamamoto N; Muto M; Mandai M
Gynecol Oncol Rep; 2022 Dec; 44():101115. PubMed ID: 36560959
[TBL] [Abstract][Full Text] [Related]
19. Genome sequencing with gene panel-based analysis for rare inherited conditions in a publicly funded healthcare system: implications for future testing.
Hocking LJ; Andrews C; Armstrong C; Ansari M; Baty D; Berg J; Bradley T; Clark C; Diamond A; Doherty J; Lampe A; McGowan R; Moore DJ; O'Sullivan D; Purvis A; Santoyo-Lopez J; Westwood P; Abbott M; Williams N; ; Aitman TJ; Miedzybrodzka Z
Eur J Hum Genet; 2023 Feb; 31(2):231-238. PubMed ID: 36474026
[TBL] [Abstract][Full Text] [Related]
20. DUSP5 and PHLDA1 mutations in mature cystic teratomas of the ovary identified on whole-exome sequencing may explain teratoma characteristics.
Wang WC; Lai YC
Hum Genomics; 2022 Oct; 16(1):50. PubMed ID: 36289533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
